Exchange: NASDAQ·Updated 08:57 AM EDT

SLBT SL Science Holding Limited Ordinary Shares

$1.78
$0.12
(7.23%)
Pre-Market
Prev Close $1.66
Mkt Cap$930.86M
Vol937.00

About SLBT

SL Science Holding Ltd. operates as a biomedical company. It operates through Exosome products, CD-19 Armed-T products, GDT cell therapy products, corporate and unallocated segments. The firm offers immune cell development, skincare product formulations, cellular and gene therapies. The company was founded by Ching Dong Wang on March 18, 2025 and is headquartered in Taipei, Taiwan.
52

Neutral Sentiment

How do you feel about SLBT?

Advertisement|Remove ads.